Download FREE Report Sample
Download Free sampleCefotaxime sodium injection is a western medicine preparation, mainly used for pneumonia and other lower respiratory tract infections caused by sensitive bacteria.Since the global outbreak of COVID-19, these drugs have also entered a stage of shortage .
Cefotaxime Sodium Injection Market contains market size and forecasts of Cefotaxime Sodium Injection in global, including the following market information:
Global Cefotaxime Sodium Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cefotaxime Sodium Injection Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cefotaxime Sodium Injection companies in 2021 (%)
The global Cefotaxime Sodium Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
1g/vial Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cefotaxime Sodium Injection include Pfizer, Hikma, Apollo Pharmaceuticals, SteriMax, Actiza Pharmaceutical, Hainan Haiyao, Tonglian Group, Hanmi Pharma and Youcare Pharmaceutical Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cefotaxime Sodium Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cefotaxime Sodium Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cefotaxime Sodium Injection Market Segment Percentages, by Type, 2021 (%)
1g/vial
2g/vial
10g/vial
Global Cefotaxime Sodium Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cefotaxime Sodium Injection Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinics
Recovery Center
Global Cefotaxime Sodium Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cefotaxime Sodium Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cefotaxime Sodium Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cefotaxime Sodium Injection revenues share in global market, 2021 (%)
Key companies Cefotaxime Sodium Injection sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cefotaxime Sodium Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Hikma
Apollo Pharmaceuticals
SteriMax
Actiza Pharmaceutical
Hainan Haiyao
Tonglian Group
Hanmi Pharma
Youcare Pharmaceutical Group
Lijian Pharm
Zhejiang Yongning Pharma
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
